Annovis Bio Inc. - notizie pubblicate 175 - letture 3.696
ANNOVIS BIO INC.
Registration Statement - Specified Transactions - Form S-3
Tm244399-1_s3 - none - 3.2187601s table of contents as filed with the securities and exchange commission on february 1, 2024 registration no. 333- united states securities and exch ...
ANNOVIS BIO INC.
January 30, 2024Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio
Tue, 30 jan 2024 malvern, pa., jan. 30, 2024 (globe newswire) -- annovis bio, inc. (nyse: anvs), a clinical-stage drug platform company developing novel therapies for neurodegenera ...
ANNOVIS BIO INC.
January 24, 2024Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data Announcement
Wed, 24 jan 2024 malvern, pa., jan. 24, 2024 (globe newswire) -- annovis bio, inc. (nyse: anvs), a clinical-stage drug platform company developing novel therapies for neurodegenera ...
ANNOVIS BIO INC.
December 11, 2023Annovis Bio to Participate in the 139th Yale CEO Summit
Mon, 11 dec 2023 berwyn, pa., dec. 11, 2023 (globe newswire) -- annovis bio, inc. (nyse: anvs), a clinical-stage drug platform company developing novel therapies for neurodegenerat ...
ANNOVIS BIO INC.
December 5, 2023Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s Disease
Tue, 05 dec 2023 berwyn, pa., dec. 05, 2023 (globe newswire) -- annovis bio, inc. (nyse: anvs), a clinical-stage drug platform company developing novel therapies for neurodegenerat ...
ANNOVIS BIO INC.
December 1, 2023Annovis Bio Appoints Andrew Walsh as Vice President Finance
Fri, 01 dec 2023 berwyn, pa., dec. 01, 2023 (globe newswire) -- annovis bio, inc. (nyse: anvs), a clinical-stage drug platform company developing novel therapies for neurodegenerat ...
ANNOVIS BIO INC.
November 27, 2023Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original Projections
Mon, 27 nov 2023 berwyn, pa., nov. 27, 2023 (globe newswire) -- annovis bio, inc. (nyse: anvs), a clinical-stage drug platform company addressing neurodegenerative diseases such as ...
ANNOVIS BIO INC.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ANNOVIS BIO INC.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ANNOVIS BIO INC.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ANNOVIS BIO INC.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ANNOVIS BIO INC.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ANNOVIS BIO INC.
Amendment to Statement of Changes in Beneficial Ownership - Form 4/A
Ownership submission form 4/a check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and excha ...
ANNOVIS BIO INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ANNOVIS BIO INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti